Jane Street Group LLC Invests $516,000 in Alpha Teknova, Inc. (NASDAQ:TKNO)

Jane Street Group LLC acquired a new position in Alpha Teknova, Inc. (NASDAQ:TKNO - Free Report) in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund acquired 61,811 shares of the company's stock, valued at approximately $516,000. Jane Street Group LLC owned 0.12% of Alpha Teknova at the end of the most recent reporting period.

Other hedge funds have also recently added to or reduced their stakes in the company. JPMorgan Chase & Co. lifted its holdings in shares of Alpha Teknova by 622.5% in the 4th quarter. JPMorgan Chase & Co. now owns 4,400 shares of the company's stock worth $37,000 after purchasing an additional 3,791 shares during the last quarter. Mount Lucas Management LP acquired a new stake in Alpha Teknova in the fourth quarter worth $75,000. China Universal Asset Management Co. Ltd. bought a new stake in Alpha Teknova in the fourth quarter valued at $94,000. NewEdge Advisors LLC boosted its holdings in shares of Alpha Teknova by 14.3% during the fourth quarter. NewEdge Advisors LLC now owns 15,632 shares of the company's stock valued at $131,000 after acquiring an additional 1,953 shares during the period. Finally, Barclays PLC acquired a new position in shares of Alpha Teknova during the fourth quarter valued at $132,000. Institutional investors and hedge funds own 13.81% of the company's stock.

Analyst Ratings Changes

Separately, Craig Hallum started coverage on shares of Alpha Teknova in a report on Monday, February 10th. They issued a "buy" rating and a $12.00 price objective on the stock.

Alpha Teknova Stock Performance

Shares of TKNO traded down $0.15 during mid-day trading on Friday, reaching $5.76. 217,587 shares of the company's stock traded hands, compared to its average volume of 395,892. Alpha Teknova, Inc. has a 12 month low of $1.16 and a 12 month high of $10.37. The stock has a market capitalization of $307.82 million, a P/E ratio of -7.78 and a beta of 0.50. The business's 50-day moving average price is $5.94 and its 200-day moving average price is $7.04. The company has a debt-to-equity ratio of 0.12, a quick ratio of 3.94 and a current ratio of 4.73.

Alpha Teknova (NASDAQ:TKNO - Get Free Report) last announced its earnings results on Thursday, May 8th. The company reported ($0.09) earnings per share for the quarter, beating the consensus estimate of ($0.11) by $0.02. Alpha Teknova had a negative return on equity of 35.30% and a negative net margin of 87.17%. The firm had revenue of $9.60 million for the quarter, compared to the consensus estimate of $9.41 million. Equities analysts predict that Alpha Teknova, Inc. will post -0.58 earnings per share for the current year.

Alpha Teknova Company Profile

Alpha Teknova, Inc produces critical reagents for the research, discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics in the United States and internationally. The company offers pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification.